Hua Medicine (Shanghai) Ltd.
HUMDF
Price:
$0.3401
Market Cap:
$1.86B
Hua Medicine (Shanghai) Ltd. is a clinical-stage pharmaceutical firm specializing in treatments for diabetes, primarily targeting the Chinese market. Its flagship product is Dorzagliatin (also known as HMS5552), an oral medication currently being developed for managing Type 2 Diabetes (T2D). Additionally, the company is advancing Dorzagliatin through Phase I clinical trials when combined with Metformin, Sitagliptin, and Empagliflozin, also for T2D therapy. Dorzagliatin's potential extends to other applications, including combinations with Pioglitazone for NASH, with GLP-1 for Alzheimer's disease, and for the management of both late-stage Type 2 and Type 1 Diabetes. Furthermore, Hua Medicine ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2021-03-15
Stock Exchange
OTC
Ticker
HUMDF
PE Ratio
[2.13]
ROE
[107.22%]
Current Ratio
[6.17]
Dividend Yield
[0%]
Enterprise Value
[1.07B]
Dividend History
The ROE as of June 2026 (TTM) for Hua Medicine (Shanghai) Ltd. (HUMDF) is 107.22%
According to Hua Medicine (Shanghai) Ltd.’s latest financial reports and current stock price. The company's current ROE is 107.22%. This represents a change of -30.00% compared to the average of 153.17% of the last 4 quarters.
Hua Medicine (Shanghai) Ltd. (HUMDF) Historical ROE (quarterly & annually)
How has HUMDF ROE performed in the past?
The mean historical ROE of Hua Medicine (Shanghai) Ltd. over the last ten years is -33.22%. The current 107.22% ROE has changed -422.80% with respect to the historical average. Over the past ten years (40 quarters), HUMDF's ROE was at its highest in in the June 2024 quarter at 428.81%. The ROE was at its lowest in in the December 2018 quarter at -149.42%.
Average
-33.22%
Median
-47.23%
Minimum
-256.70%
Maximum
184.65%
Hua Medicine (Shanghai) Ltd. (HUMDF) ROE by Quarter and Year
Discovering the peaks and valleys of Hua Medicine (Shanghai) Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 186.53%
Maximum Annual ROE = 184.65%
Minimum Annual Increase = -997.86%
Minimum Annual ROE = -256.70%
| Year | ROE | Change |
|---|---|---|
| 2025 | 107.04% | -42.03% |
| 2024 | 184.65% | -188.42% |
| 2023 | -208.83% | 186.53% |
| 2022 | -72.88% | -0.83% |
| 2021 | -73.49% | 35.79% |
| 2020 | -54.12% | 34.15% |
| 2019 | -40.34% | -84.28% |
| 2018 | -256.70% | -997.86% |
| 2017 | 28.59% | -46.98% |
Hua Medicine (Shanghai) Ltd. (HUMDF) Average ROE
How has HUMDF ROE performed in the past?
The current ROE of Hua Medicine (Shanghai) Ltd. (HUMDF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
27.62%
5-year avg
-12.70%
10-year avg
-33.22%
Hua Medicine (Shanghai) Ltd. (HUMDF) ROE vs. Peers
How is HUMDF’s ROE compared to its peers?
Hua Medicine (Shanghai) Ltd.’s ROE is less than Allergy Therapeutics plc (409.00%), greater than Knight Therapeutics Inc. (0.73%), less than Boiron S.A. (8.57%), greater than Cresco Labs Inc. (-35.26%), greater than PureTech Health plc (-31.98%), less than Clinuvel Pharmaceuticals Limited (13.29%), less than Hansa Biopharma AB (publ) (201.60%), less than Nika Pharmaceuticals Inc. (27.39%), greater than Verano Holdings Corp. (-33.23%), less than Ion Beam Applications S.A. (10.28%),
| Company | ROE | Market cap |
|---|---|---|
| 409.00% | $655.46M | |
| 0.73% | $657.80M | |
| 8.57% | $553.86M | |
| -35.26% | $290.46M | |
| -31.98% | $413.81M | |
| 13.29% | $348.84M | |
| 201.60% | $245.80M | |
| 27.39% | $534.55M | |
| -33.23% | $470.36M | |
| 10.28% | $566.03M |
Build a custom stock screener for Hua Medicine (Shanghai) Ltd. (HUMDF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hua Medicine (Shanghai) Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Hua Medicine (Shanghai) Ltd. (HUMDF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Hua Medicine (Shanghai) Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Hua Medicine (Shanghai) Ltd.'s ROE?
How is the ROE calculated for Hua Medicine (Shanghai) Ltd. (HUMDF)?
What is the highest ROE for Hua Medicine (Shanghai) Ltd. (HUMDF)?
What is the 3-year average ROE for Hua Medicine (Shanghai) Ltd. (HUMDF)?
What is the 5-year average ROE for Hua Medicine (Shanghai) Ltd. (HUMDF)?
How does the current ROE for Hua Medicine (Shanghai) Ltd. (HUMDF) compare to its historical average?